Intelliheart tests in Amcal pharmacies

By Dylan Bushell-Embling
Friday, 13 June, 2008

IM Medical (ASX: IMI) has reached an exclusive agreement with Sigma Pharmaceuticals that will see the Intelliheart cardiac risk assessment tests sold through Sigma's Amcal network.

The Amcal network includes over 700 Amcal, Amcal Max and Guardian pharmacies throughout the country.

The product will initially be rolled out to over 200 pharmacies throughout Victoria in July. Stores in other states will begin stocking the product in the next few months.

Under the agreement Sigma has the right to produce and market other products using the Intelliheart brand name.

Intelliheart is the only widely available diagnostic which tests for both heart rate variability and arterial stiffness.

Related News

Sunscreen and supplements can lower your vitamin D levels

People who use SPF50+ sunscreen daily are more likely to be vitamin D deficient, while taking...

Low-dose drug prevents diabetes progression in young people

A low dose of the immunomodulatory drug anti-thymocyte globulin (ATG) appears safe and effective...

Mediterranean-style diet benefits maternal and infant health

Two studies have found that a Mediterranean-style diet benefits maternal health during pregnancy...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd